Chiral Pharma Corporation advised the public to be wary of many fake social media posts claiming CytoDyn’s investigational drug product leronlimab is being sold for hundreds of thousands to millions of pesos.
In fact, the initial 400 vials made available by CytoDyn Inc. through Chiral Pharma are being distributed for free for use in various hospitals in the country by critically ill COVID-19 patients under a Compassionate Special Permit (CSP) issued by the Food and Drug Administration (FDA).
Leronlimab (PRO 140) is a humanized monoclonal antibody developed by CytoDyn Inc., a late-stage biotechnology company.
The immunomodulatory agent is now being used on critically ill patients due to its ability to mitigate the cytokine storm, which is common in COVID-19 fatalities.
Chiral Pharma Corporation is grateful for its partnership with CytoDyn Inc. in making this drug available to Filipinos as the upsurge in the number of COVID-19 cases continue.
More importantly, Chiral Pharma Corporation is grateful to the regulatory officers, logistics providers, healthcare
institutions, pharmacists, and physicians who are working tirelessly hand-in-hand with its patient’s families to provide leronlimab in time to make an important difference.
The company said that in times like these, it is paramount that people get the most accurate data and information to be instrumental in saving lives.